This Week in Psychedelics - 12.24.21

Cannabis

• Analysis: Unregulated Delta-8 Vape Products Frequently Mislabeled, May Contain Heavy Metals (NORML)

• Malta Officially Legalizes Marijuana With President’s Signature, Becoming First In Europe To End Cannabis Prohibition (Marijuana Moment)

• Several States to Usher In the New Year with Cannabis Liberalization Laws (NORML)

• The Next States to Legalize Recreational Marijuana (MSN)

• Pfizer Bets On Medical Cannabis With $6.7 Billion Acquisition (Forbes)

• Scientists are (finally) studying how weed affects athletic performance and recovery (Leafly)

• New York Senator Files Bill To Extend Marijuana Equity Benefits To Gay, Lesbian And Bisexual People (Marijuana Moment)

• Cartels Ditch Pot and Opium Fields for Synthetic Drugs, Mexico Defense Secretary Says (High Times)

• Ohio: Citizens’ Petition Seeks to Compel Lawmakers to Hold Marijuana Legalization Vote (NORML)

• Senator Calls For Federal Marijuana Standard To Measure Impaired Driving (Marijuana Moment)

• Top Maryland Lawmaker Files Marijuana Legalization Referendum For 2022 Ballot (Marijuana Moment)

• Iowa Democrats Announce Plan To Let Voters Decide On Marijuana Legalization Amid GOP Resistance (Marijuana Moment)

• Whole-Plant Cannabis Extract Reduces Epileptic Seizures By 86% in Small Study (High Times)

• Researcher Uses Reddit To Learn What Kinds Of Marijuana Posts Influenced Legalization Attitudes (Marijuana Moment)

• Pair of Cops Booked After Being Caught Smoking Pot in Mississippi (High Times)

• Marijuana Group Releases ‘Robbery Preparedness Guide’ For Dispensaries Amid Spike In Thefts (Marijuana Moment)

• Dr. Sanjay Gupta adds to chorus of cannabis research on autism in 2021 (Leafly)

• Legal Cannabis Outsells Ontario Illicit Market for First Time (High Times)

• These were the weirdest weed news stories of 2021 (Leafly)

LSD

• U.S. FDA puts plans to test LSD in anxiety patients in clinical study on hold (Reuters)

Magic Mushrooms

• Canada’s Psilocybin Policy Reform Movement Continues to Make Progress Federally (Truffle Report)

• FDA Approves Psilocybin For Binge Eating Study By Tryp Therapeutics (Benzinga)

Ayahuasca

• Global ayahuasca trend drives deforestation in Brazil’s Acre state (Mongabay)

Morning Glory Seeds

• Study shows common flower species holds promise for beneficial psychedelic drugs (Newswise)

Ketamine

• Ketamine Therapy Quickly Reduces Depression and Suicidal Thoughts (SciTechDaily)

DXM

• Cough medicine creates dangerous interaction (The Seattle Times)

Miscellaneous

• Port Townsend Becomes 13th City to Decriminalize Psychedelics (DoubleBlind)

• Psychedelics: The newest tool in nuclear negotiations? (Bulletin of the Atomic Scientists)

• How Should Psychedelic Medicine Handle “Flashbacks”? (Mad in America)

• New center to study psychedelics pops up at University of Texas at Austin (My San Antonio)

• The Dumbest Drug Scare Stories of 2021 (VICE)

• DEA Wants To Help Parents Decode The Emojis Young People Use To Discuss Marijuana And Other ‘Bomb Ass’ Drugs (Marijuana Moment)

• GOP Lawmakers File Bills To Streamline Research Into Marijuana, Psychedelics And Other Schedule I Drugs (Marijuana Moment)

• Colorado Ballot Initiatives Filed to Legalize Psychedelics (Truffle Report)

• Two Leaders in Psychedelics Industry and the Harm Reduction Approach (Nasdaq)

• How Do Hallucinogenic Drugs Change Our Personality? (Psychology Today)

• Microdosing companion app Houston wants to be your guide to 'inner space' (Mashable)

• Why Psychedelic Research May Bring the Next Big Breakthrough in Dementia Treatment (Psychedelic Spotlight)

• MYND Life Sciences Acquires Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and other Dementias (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 12.3.21

Cannabis

• Home of Dubai, the United Arab Emirates, Ends Jail Time for Travelers with THC (High Times)

• Mexico has a new marijuana legalization bill. Here’s what’s in it (Leafly)

• Reps. Dave Joyce and Alexandria Ocasio-Cortez Introduce Legislation To Expunge Marijuana Records (NORML)

• South Dakota's Governor Succeeds in Blocking Voter-Approved Marijuana Legalization (Reason)

• Fentanyl-laced vape pens among teens concern after Tennessee high school incident (WKYT)

• Record Number of Scientific Papers Published About Cannabis in 2021 (NORML)

• Death sentences upheld for two men convicted of cannabis trafficking (Singapore Law Watch)

• California rolls out plans to standardize cannabis testing statewide (Marijuana Business Daily)

• Jamaican Government Launches ‘Good Ganja Sense’ Campaign To Debunk Marijuana Myths (Marijuana Moment)

• Great News, Scientists Finally Figured Out Why Cannabis Smells 'Skunky' (ScienceAlert)

• Texas Activists Turn In Signatures To Put Marijuana Decriminalization On Austin’s 2022 Ballot (Marijuana Moment)

• Kentucky Lawmaker Pre-Files Marijuana Legalization Bills For 2022 Session (Marijuana Moment)

• Colorado University Announces Groundbreaking Study on Cannabis and Exercise (High Times)

• Massachusetts: Majority of Adults Say Marijuana Legalization Has Been “Positive” for the State (NORML)

LSD

• Blotter paper should be included while measuring weight of LSD, rules Bombay HC (India Today)

• How LSD changed The Beatles forever (Far Out Magazine)

Magic Mushrooms

• New Study Suggests SSRI Drugs Can Be Used Safely with Psilocybin to Treat Depression (Psychedelic Spotlight)

• Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress (Psilocybin Alpha)

• U of M Medical School launches new mechanistic study of psilocybin (University of Minnesota)

Ayahuasca

• Sexual Assault in the Amazon (The Cut)

Iboga

• Ibogaine and Cardiac Arrhythmia: The Heart of the Matter (Psychedelic Science Review)

Novel Psychoactive Substances

• MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation (Psilocybin Alpha)

• Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic Program for the Treatment of Mental Diseases (Psilocybin Alpha)

Nitrous Oxide

• ‘Everyone’s gagging for it’ – how Britain got high on nitrous oxide (The Guardian)

• Dozens of traffic accident deaths linked to laughing gas use (NL Times)

Ketamine

• Ketamine review: Chemical restraints may have been ‘disproportionately’ used on ‘communities of color’ (KDVR)

• As ketamine clinics emerge in Seattle to treat mental illness, so does debate about safety and regulations (The Seattle Times)

• PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent Portfolio (Psilocybin Alpha)

Miscellaneous

• New York City Opens First Safe Consumption Sites For Illegal Drugs In The U.S. (Marijuana Moment)

• Florida Lawmaker Files Bill To Decriminalize All Currently Illicit Drugs (Marijuana Moment)

• Toronto May Be the Next City to Decriminalize Psychedelics and Other Drugs (Truffle Report)

• Study Shows People Who Use Psychedelics Were Under Less Stress During Covid-19 Lockdowns (Forbes)

• DEA Again Boosts 2022 Production Goals For Psychedelics Like Psilocybin, MDMA and DMT (Marijuana Moment)

• People ‘microdosing’ psychedelics to improve wellbeing during pandemic, drug survey finds (The Independent)

• Psychedelics may have long-term impact treating depression, mental illness - study (The Jerusalem Post)

• Psychedelic Telemedicine Has Arrived. What Could Possibly Go Wrong? (VICE)

• The Psychedelic Renaissance Is Ushering In a New Genre Of Electronic Music — And With It, New Revenue Streams (Billboard)

• Holiday Gift Guide 2021: Gifts For The Psychedelic Explorer (Forbes)

• Can ethics and sexual abuse allegations create backlash and impact the current psychedelic renaissance? (Chacruna)

• Will the psychedelic revolution bypass people of color? (The Lens)

• Celebrities: Are They Helping or Harming the Psychedelic Movement? (Psychedelic Spotlight)

• Origin Therapeutics Portfolio Company Tripsitter has Commenced Trading on the Canadian Securities Exchange (GlobeNewswire)

• Peter Thiel-backed psychedelic start-up increases stake in Compass Pathways (CNBC)

• Microdosing Protocols: Microdosing Every Day vs. Every Other Day (DoubleBlind)

• Editor’s Choice Award 2021-Best Study on Psychedelics and Neurochemistry (Psychedelic Science Review)

• Novel Psychedelic Treatment Approach Bypasses Hallucinogenic Effects to Allow Widespread Adoption (Pharmacy Times)

• Israeli start up makes pharmaceuticals out of psychedelic flora (i24 News)

• Getting Ahead of the Psychedelics Supply Crunch (Truffle Report)

• Numinus Develops Proprietary Psychedelic Tests with New Toxicity and Potency Scans (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.